Table 4. Cytokine production and disease characteristics.
TNF-α [IQR] | P value | IL-1β [IQR] | P value | IL-6 [IQR] | P value | IL-10 [IQR] | P value | |
---|---|---|---|---|---|---|---|---|
HC (n = 24) | 428 [267–468] | 679 [565–878] | 2687 [1830–3228] | 80 [61–149] | ||||
Localization | ||||||||
L1 (n = 33) | 454 [362–624] | 561 [356–903] | 2384 [1585–3017] | 89 [65–107] | ||||
L2 (n = 8) | 516 [469–560] | 603 [237–1243] | 2715 [1701–3465] | 64 [30–83] | ||||
L3 (n = 28) | 421 [354–561] | 0.41 | 568 [387–750] | 0.90 | 2395 [1756–2830] | 0.79 | 81 [55–112] | 0.22 |
P—(n = 48) | 452 [368–573] | 569 [380–901] | 2384 [1711–2872] | 88 [64–111] | ||||
P + (n = 21) | 483 [325–575] | 0.98 | 560 [272–747] | 0.58 | 2491 [1469–3332] | 0.92 | 75 [55–107] | 0.32 |
Behavior | ||||||||
No fistulas (n = 31) | 454 [400–563] | 561 [384–905] | 2417 [1707–2816] | 79 [55–107] | ||||
Fistulas (n = 38) | 462 [350–579] | 0.55 | 568 [298–813] | 0.62 | 2351 [1567–3305] | 0.81 | 82 [62–108] | 0.50 |
No strictures (= 25) | 408 [351–584] | 511 [254–859] | 2402 [1691–3062] | 90 [67–114] | ||||
Strictures (n = 44) | 476 [387–573] | 0.38 | 569 [400–866] | 0.45 | 2384 [1703–3049] | 0.92 | 77 [54–107] | 0.12 |
Extra intestinal manifestations | ||||||||
No arthralgia (n = 51) | 454 [373–578] | 577 [379–902] | 2445 [1706–3045] | 85 [62–106] | ||||
Arthralgia (n = 18) | 476 [348–562] | 0.90 | 550 [261–796] | 0.51 | 2204 [1588–3088] | 0.46 | 82 [53–124] | 0.77 |
Cytokine levels (pg/ml) are presented as medians with the interquartile range [IQR]. HC, Healthy control; TNF-α, Tumor necrosis factor alpha; IL, Interleukin; L1, ileal disease; L2, colonic disease; L3, ileocolonic disease; P-, no peri-anal disease; P+, peri-anal disease; IQR, interquartile range.